Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1175 results found. Search for [ Pharma industry ]

Results 1 to 21 of 1175
Joe C Mathew
New Delhi, December 10, 2019
According to AIDAN, the agreements the company has drawn up with doctors in the guise of consultancy are not only illegitimate and unethical, but also undermine the medical practitioner's autonomy and professional integrity


Anil Sarin
December 4, 2019
While predicting winners is inherently risky, we find that sectors like real estate (RE), staffing companies, and companies with internet and Mobile driven business models are positioned quite well


E Kumar Sharma
December 2, 2019
Earlier this month, AstraZeneca announced three large-scale initiatives to build on the company's long-standing commitment to China and advance global R&D for innovative new medicines


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


Rashmi Pratap
November 13, 2019
These companies cut across sectors and include Vakrangee, PC Jeweller, Arvind, Rain Industries and Indiabulls Real Estate, among others. Most may never go back to their past highs


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
November 7, 2019
Benchmark indices climbed to record high levels gaining 0.40% each by the closing bell today, backed by strong global equities after China said it agreed with the US to roll back tariffs imposed during their prolonged trade war. While Sensex made its highest closing at 40,653, Nifty ended above 12K mark at 12,016 for the first time after June 2019, backed by gains in industry heavyweight HDFC.Top Nifty gainers included Sun Pharma, IndusInd Bank, Bharti Infratel, Hindalco Industries and JSW St...


BusinessToday.In
New Delhi, November 7, 2019
Sun Pharma Q2 results: India sales, which accounted for 31.6 per cent of total consolidated sales, rose 35 per cent year-on-year (YoY) to Rs 2,515 crore in September quarter of this fiscal


PTI
November 4, 2019



BusinessToday.In
New Delhi, October 30, 2019
Sixteen CEOs and economists lay out a roadmap to revive the economy


BusinessToday.In
October 30, 2019
Ajanta Pharma share price which stood at Rs 12.41 on October 30, 2009 has risen to Rs 1,020 during the period.


BusinessToday.In
October 29, 2019
While Sensex made an intraday high of 39,917, Nifty crossed 11,800 level for the first time since July 5 to touch 11,809.40 mark intraday.


BusinessToday.In
Bhopal, October 17, 2019
R S Goswami, President, Federation of Madhya Pradesh Chambers of Commerce and Industry, said that state government should focus on improving value chain, ease of doing business and single window clearance system to boost manufacturing clusters and help the sector compete with China, UK, Vietnam and South Korea


Goutam Das
New Delhi, October 13, 2019
The company doesn't sell directly to bars. It markets via distributors. A well thought out distributor strategy has now made the company stand out in many parts of the southern market.


BusinessToday.In
October 10, 2019
While most key industries, including the IT sector, BPO, pharma, FMCG, construction and telecom posted positive hiring growth rates ranging from 3-33 per cent, the slowdown continues to reflect in the auto and banking industries


PTI
October 3, 2019
\"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience,\" Lupin said in a statement


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


Reuters
New Delhi, September 27, 2019
The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'


PAGES 1 OF 59  12345